A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

1,533

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 14, 2019

Study Completion Date

November 14, 2019

Conditions
Prostate CancerCastration-resistant Prostate CancerMetastatic Prostate Cancer
Trial Locations (93)

333

Site, Guishan Township

622

Site, Tauranga

807

Site, Kaohsiung City

1060

Site, Buenos Aires

1090

Site, Vienna

1229

Site, Makati

1502

Site, San Juan City

1600

Site, Pasig

2444

Site, Port Macquarie

2485

Site, Tweed Heads

3050

Site, Parkville

3121

Site, Richmond

3140

Site, Tauranga

3204

Site, Hamilton

5037

Site, Kurralta Park

6300

Site, La Pampa

7743

Site, Jena

8013

Site, Christchurch

8035

Site, Vall d'Hebron 119-129

8208

Site, Sabadell

10002

Site, Taipei

10043

Site, Orbassano

10400

Site, Bangkok

Site, Phayathai

10430

Site, Jakarta

11211

Site, Taipei

11411

Site, Riyadh

11566

Site, Cairo

11796

Site, Cairo

12411

Site, Cairo

14197

Site, Berlin

16005

Site, Algiers

16006

Site, Algiers

18107

Site, Rostock

20133

Site, Milan

20246

Site, Hamburg

25030

Site, Besançon

25123

Site, Brescia

26100

Site, Cremona

28050

Site, Madrid

30029

Site, Nîmes

31096

Site, Haifa

34000

Site, Durango

40447

Site, Taichung

59037

Site, Lille

69310

Site, Pierre-Bénite

70300

Site, Beer Ya'akov

72622

Site, Nürtingen

76001

Site, Santiago de Cali

79106

Site, Freiburg im Breisgau

81362

Site, Kaohsiung City

86021

Site, Poitiers

89075

Site, Ulm

90110

Site, Porto Alegre

Site, Songkhla

92151

Site, Suresnes

94163

Site, Saint-Mandé

110221

Site, Bogotá

111321

Site, Bogotá

116301

Site, Beirut

119228

Site, Singapore

166830

Site, Beirut

169610

Site, Singapore

258499

Site, Singapore

308433

Site, Singapore

602739

Site, Busan

BP 190

Site, Blida

C1120AAT

Site, Paraje Cabal

30130-100

Site, Belo Horizonte

98700-000

Site, Ijuí

Unknown

Site, Passo Fundo

Site, Muscat

01246-000

Site, São Paulo

95070-560

Site, Caxias do Sul

09060-650

Site, Santo André

J2G8Z9

Site, Granby

G1R 2J6

Site, Québec

1105 AZ

Site, Amsterdam

6525 GA

Site, Nijmegen

Lima18

Site, Miraflores

Lima 01

Site, Lima

Lima 18

Site, Lima

431-070

Site, Anyang

602-714

Site, Busan

405-760

Site, Incheon

110-746

Site, Seoul

137-701

Site, Seoul

139-872

Site, Seoul

442-723

Site, Suwon

HU17 8SX

Site, Hull

SE1 9RT

Site, London

NE7 7DN

Site, Newcastle upon Tyne

SR4 7TP

Site, Sunderland

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT02066961 - A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter